Abstract
Both the innate and adaptive immune systems are critical for the maintenance of healthy liver function. Immune activity maintains the tolerogenic capacity of the liver, modulates hepatocellular response to various stresses, and orchestrates appropriate cellular repair and turnover. However, in response to heavy, chronic alcohol exposure, the finely tuned balance of pro- and anti-inflammatory functions in the liver is disrupted, leading to a state of chronic inflammation in the liver. Over time, this non-resolving inflammatory response contributes to the progression of alcoholic liver disease (ALD). Here we review the contributions of the cellular components of the immune system to the progression of ALD, as well as the pathophysiological roles for soluble and circulating mediators of immunity, including cytokines, chemokines, complement, and extracellular vesicles, in ALD. Finally, we compare the role of the innate immune response in health and disease in the liver to our growing understanding of the role of neuroimmunity in the development and maintenance of a healthy central nervous system, as well as the progression of neuroinflammation.
Adam Kim, Rebecca L. McCullough, Kyle L. Poulsen, Carlos Sanz-Garcia, and Megan Sheehan equally contributed to this work.
Abram B. Stavitsky posthumous contribution.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe M, Hiasa Y, Onji M (2013) T helper 17 cells in autoimmune liver diseases. Clin Dev Immunol 2013:607073. https://doi.org/10.1155/2013/607073
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499–511. https://doi.org/10.1038/nri1391
Albano E (2012) Role of adaptive immunity in alcoholic liver disease. Int J Hepatol 2012:893026. https://doi.org/10.1155/2012/893026
Altamirano J, Miquel R, Katoonizadeh A, Abraldes JG, Duarte-Rojo A, Louvet A, Augustin S, Mookerjee RP, Michelena J, Smyrk TC, Buob D, Leteurtre E, Rincon D, Ruiz P, Garcia-Pagan JC, Guerrero-Marquez C, Jones PD, Barritt AS 4th, Arroyo V, Bruguera M, Banares R, Gines P, Caballeria J, Roskams T, Nevens F, Jalan R, Mathurin P, Shah VH, Bataller R (2014) A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology 146(5):1231–1239.e1-6. https://doi.org/10.1053/j.gastro.2014.01.018
An L, Wang X, Cederbaum AI (2012) Cytokines in alcoholic liver disease. Arch Toxicol 86(9):1337–1348. https://doi.org/10.1007/s00204-012-0814-6
Bala S, Csak T, Saha B, Zatsiorsky J, Kodys K, Catalano D, Satishchandran A, Szabo G (2016) The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol 64(6):1378–1387. https://doi.org/10.1016/j.jhep.2016.01.035
Ballas ZK, Cook RT, Shey MR, Coleman RA (2012) A dynamic flux in natural killer cell subsets as a function of the duration of alcohol ingestion. Alcohol Clin Exp Res 36(5):826–834. https://doi.org/10.1111/j.1530-0277.2011.01678.x
Bamboat ZM, Ocuin LM, Balachandran VP, Obaid H, Plitas G, DeMatteo RP (2010) Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120(2):559–569. https://doi.org/10.1172/JCI40008
Bang C, Thum T (2012) Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol 44(11):2060–2064. https://doi.org/10.1016/j.biocel.2012.08.007
Barnes MA, McMullen MR, Roychowdhury S, Pisano SG, Liu X, Stavitsky AB, Bucala R, Nagy LE (2013) Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 57(5):1980–1991. https://doi.org/10.1002/hep.26169
Bertola A, Park O, Gao B (2013) Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology 58(5):1814–1823. https://doi.org/10.1002/hep.26419
Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z (2004) Cell signals transduced by complement. Mol Immunol 41(6–7):583–597. https://doi.org/10.1016/j.molimm.2004.04.007
Ceni E, Mello T, Galli A (2014) Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol 20(47):17756–17772. https://doi.org/10.3748/wjg.v20.i47.17756
Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354(6):610–621. https://doi.org/10.1056/NEJMra052723
Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, Roselle GA, Nemchausky BA, Tamburro CH, Schiff ER et al (1993) Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology 105(1):254–266
Chen L, Charrier A, Zhou Y, Chen R, Yu B, Agarwal K, Tsukamoto H, Lee LJ, Paulaitis ME, Brigstock DR (2014) Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59(3):1118–1129. https://doi.org/10.1002/hep.26768
Chen L, Chen R, Kemper S, Charrier A, Brigstock DR (2015) Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1. Am J Physiol Gastrointest Liver Physiol 309(6):G491–G499. https://doi.org/10.1152/ajpgi.00140.2015
Chen P, Miyamoto Y, Mazagova M, Lee KC, Eckmann L, Schnabl B (2016a) Microbiota and alcoholic liver disease. Alcohol Clin Exp Res 40(8):1791–1792. https://doi.org/10.1111/acer.13129
Chen L, Chen R, Velazquez VM, Brigstock DR (2016b) Fibrogenic signaling is suppressed in hepatic stellate cells through targeting of connective tissue growth factor (CCN2) by cellular or exosomal microRNA-199a-5p. Am J Pathol 186(11):2921–2933. https://doi.org/10.1016/j.ajpath.2016.07.011
Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, Nagy LE (2010) Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139(2):664–674.e1. https://doi.org/10.1053/j.gastro.2010.04.041
Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, CaballerÃa J, Ginès P (2007) Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 132(2):687–697. https://doi.org/10.1053/j.gastro.2006.12.036
Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A, Pachter HL, Bar-Sagi D, Frey AB, Miller G (2009) In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 119(11):3213–3225. https://doi.org/10.1172/JCI37581
Cook RT, Waldschmidt TJ, Ballas ZK, Cook BL, Booth BM, Stewart BC, Garvey MJ (1994) Fine T-cell subsets in alcoholics as determined by the expression of L-selectin, leukocyte common antigen, and beta-integrin. Alcohol Clin Exp Res 18(1):71–80
Cook RT, Ballas ZK, Waldschmidt TJ, Vandersteen D, LaBrecque DR, Cook BL (1995) Modulation of T-cell adhesion markers, and the CD45R and CD57 antigens in human alcoholics. Alcohol Clin Exp Res 19(3):555–563
Cook RT, Waldschmidt TJ, Cook BL, Labrecque DR, McLatchie K (1996) Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics. Clin Exp Immunol 103(2):304–310
Cresci GA, Allende D, McMullen MR, Nagy LE (2015) Alternative complement pathway component factor D contributes to efficient clearance of tissue debris following acute CCl(4)-induced injury. Mol Immunol 64(1):9–17. https://doi.org/10.1016/j.molimm.2014.10.017
Cui K, Yan G, Xu C, Chen Y, Wang J, Zhou R, Bai L, Lian Z, Wei H, Sun R, Tian Z (2015) Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1beta in mice. J Hepatol 62(6):1311–1318. https://doi.org/10.1016/j.jhep.2014.12.027
Dominguez M, Miquel R, Colmenero J, Moreno M, Garcia-Pagan JC, Bosch J, Arroyo V, Gines P, Caballeria J, Bataller R (2009) Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 136(5):1639–1650. https://doi.org/10.1053/j.gastro.2009.01.056
Fearon DT, Locksley RM (1996) The instructive role of innate immunity in the acquired immune response. Science 272(5258):50–53
Fleshner M, Crane CR (2017) Exosomes, DAMPs and miRNA: features of stress physiology and immune homeostasis. Trends Immunol. https://doi.org/10.1016/j.it.2017.08.002
Gao B (2012) Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 27(Suppl 2):89–93. https://doi.org/10.1111/j.1440-1746.2011.07003.x
Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572–1585. https://doi.org/10.1053/j.gastro.2011.09.002
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S (2011) Innate immunity in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 300(4):G516–G525. https://doi.org/10.1152/ajpgi.00537.2010
He Y, Feng D, Li M, Gao Y, Ramirez T, Cao H, Kim SJ, Yang Y, Cai Y, Ju C, Wang H, Li J, Gao B (2017) Hepatic mitochondrial DNA/toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice. Hepatology 66(1):220–234. https://doi.org/10.1002/hep.29153
Heinz R, Waltenbaugh C (2007) Ethanol consumption modifies dendritic cell antigen presentation in mice. Alcohol Clin Exp Res 31(10):1759–1771. https://doi.org/10.1111/j.1530-0277.2007.00479.x
Hilscher M, Shah V (2016) Alcoholic liver disease. In: Practical gastroenterology and hepatology board review toolkit. Wiley, pp 498–502. doi:https://doi.org/10.1002/9781119127437.ch79
Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, Gores GJ, Malhi H (2016) Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology 64(6):2219–2233. https://doi.org/10.1002/hep.28814
Hishinuma I, Nagakawa J, Hirota K, Miyamoto K, Tsukidate K, Yamanaka T, Katayama K, Yamatsu I (1990) Involvement of tumor necrosis factor-alpha in development of hepatic injury in galactosamine-sensitized mice. Hepatology 12(5):1187–1191
Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z (2011) Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. Hepatology 53(1):219–229. https://doi.org/10.1002/hep.23983
Ju C, Mandrekar P (2015) Macrophages and alcohol-related liver inflammation. Alcohol Res 37(2):251–262
Karakucuk I, Dilly SA, Maxwell JD (1989) Portal tract macrophages are increased in alcoholic liver disease. Histopathology 14(3):245–253
Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50(1):261–274. https://doi.org/10.1002/hep.22950
Kovalenko EI, Streltsova MA, Kanevskiy LM, Erokhina SA, Telford WG (2017) Identification of human memory-like NK cells. Curr Protoc Cytom 79:9.50.1–9.50.11. https://doi.org/10.1002/cpcy.13
Kumar V (2013) NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol 59(3):618–620
Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A (2007) Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res 31(5):846–854. https://doi.org/10.1111/j.1530-0277.2007.00377.x
Lau AH, Abe M, Thomson AW (2006) Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo. J Leukoc Biol 79(5):941–953. https://doi.org/10.1189/jlb.0905517
Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Deviere J (2009) The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 49(2):646–657. https://doi.org/10.1002/hep.22680
Li M, He Y, Zhou Z, Ramirez T, Gao Y, Gao Y, Ross RA, Cao H, Cai Y, Xu M, Feng D, Zhang P, Liangpunsakul S, Gao B (2017) MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils. Gut 66(4):705–715. https://doi.org/10.1136/gutjnl-2016-311861
Liu YK (1973) Leukopenia in alcoholics. Am J Med 54(5):605–610
Liu YZ, Wang YX, Jiang CL (2017) Inflammation: the common pathway of stress-related diseases. Front Hum Neurosci 11:316. https://doi.org/10.3389/fnhum.2017.00316
Louvet A, Mathurin P (2015) Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 12(4):231–242. https://doi.org/10.1038/nrgastro.2015.35
Mandal P, Pritchard MT, Nagy LE (2010) Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway. World J Gastroenterol 16(11):1330–1336
Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D (2011) An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 54(6):2185–2197. https://doi.org/10.1002/hep.24599
Maricic I, Sheng H, Marrero I, Seki E, Kisseleva T, Chaturvedi S, Molle N, Mathews SA, Gao B, Kumar V (2015) Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice. Hepatology 61(4):1357–1369. https://doi.org/10.1002/hep.27632
Marin V, Poulsen K, Odena G, McMullen MR, Altamirano J, Sancho-Bru P, Tiribelli C, Caballeria J, Rosso N, Bataller R, Nagy LE (2017) Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients. J Hepatol. https://doi.org/10.1016/j.jhep.2017.06.014
Marra F, Tacke F (2014) Roles for chemokines in liver disease. Gastroenterology 147(3):577–594.e571. https://doi.org/10.1053/j.gastro.2014.06.043
Massey VL, Poole LG, Siow DL, Torres E, Warner NL, Schmidt RH, Ritzenthaler JD, Roman J, Arteel GE (2015) Chronic alcohol exposure enhances lipopolysaccharide-induced lung injury in mice: potential role of systemic tumor necrosis factor-alpha. Alcohol Clin Exp Res 39(10):1978–1988. https://doi.org/10.1111/acer.12855
Mathews S, Feng D, Maricic I, Ju C, Kumar V, Gao B (2016) Invariant natural killer T cells contribute to chronic-plus-binge ethanol-mediated liver injury by promoting hepatic neutrophil infiltration. Cell Mol Immunol 13(2):206–216. https://doi.org/10.1038/cmi.2015.06
Matzinger P (2002) An innate sense of danger. Ann N Y Acad Sci 961:341–342
McCarthy GM, Warden AS, Bridges CR, Blednov YA, Harris RA (2017) Chronic ethanol consumption: role of TLR3/TRIF-dependent signaling. Addict Biol. https://doi.org/10.1111/adb.12539
McClain CJ, Barve S, Barve S, Deaciuc I, Hill DB (1998) Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22(5 Suppl):248S–252S
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Nagy LE (2018) Complement factor D protects mice from ethanol-induced inflammation and liver injury. Am J Physiol (under review)
McFarland W, Libre EP (1963) Abnormal leukocyte response in alcoholism. Ann Intern Med 59:865–877
McFarlane IG (2000) Autoantibodies in alcoholic liver disease. Addict Biol 5(2):141–151. https://doi.org/10.1080/13556210050003720
Min JS, DeAngelis RA, Reis ES, Gupta S, Maurya MR, Evans C, Das A, Burant C, Lambris JD, Subramaniam S (2016) Systems analysis of the complement-induced priming phase of liver regeneration. J Immunol 197(6):2500–2508. https://doi.org/10.4049/jimmunol.1600628
Momen-Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep 5:9991. https://doi.org/10.1038/srep09991
Montesinos J, Alfonso-Loeches S, Guerri C (2016) Impact of the innate immune response in the actions of ethanol on the central nervous system. Alcohol Clin Exp Res 40(11):2260–2270. https://doi.org/10.1111/acer.13208
Mottaran E, Stewart SF, Rolla R, Vay D, Cipriani V, Moretti M, Vidali M, Sartori M, Rigamonti C, Day CP, Albano E (2002) Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radic Biol Med 32(1):38–45
Murray PJ (2017) Macrophage polarization. Annu Rev Physiol 79:541–566. https://doi.org/10.1146/annurev-physiol-022516-034339
Nagy LE (2015) The role of innate immunity in alcoholic liver disease. Alcohol Res 37(2):237–250
Nakamoto N, Kanai T (2014) Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol 5:221. https://doi.org/10.3389/fimmu.2014.00221
Ness KJ, Fan J, Wilke WW, Coleman RA, Cook RT, Schlueter AJ (2008) Chronic ethanol consumption decreases murine Langerhans cell numbers and delays migration of Langerhans cells as well as dermal dendritic cells. Alcohol Clin Exp Res 32(4):657–668. https://doi.org/10.1111/j.1530-0277.2007.00614.x
Neuman MG, Maor Y, Nanau RM, Melzer E, Mell H, Opris M, Cohen L, Malnick S (2015) Alcoholic liver disease: role of cytokines. Biomol Ther 5(3):2023–2034. https://doi.org/10.3390/biom5032023
O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51(1):307–328. https://doi.org/10.1002/hep.23258
Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B (2009) Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49(5):1683–1694. https://doi.org/10.1002/hep.22813
Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS, Young HA, Gao B (2011) In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54(1):252–261. https://doi.org/10.1002/hep.24339
Pasala S, Barr T, Messaoudi I (2015) Impact of alcohol abuse on the adaptive immune system. Alcohol Res 37(2):185–197
Pascual M, Fernandez-Lizarbe S, Guerri C (2011) Role of TLR4 in ethanol effects on innate and adaptive immune responses in peritoneal macrophages. Immunol Cell Biol 89(6):716–727. https://doi.org/10.1038/icb.2010.163
Pearce EJ, Everts B (2015) Dendritic cell metabolism. Nat Rev Immunol 15(1):18–29. https://doi.org/10.1038/nri3771
Petrasek J, Dolganiuc A, Csak T, Nath B, Hritz I, Kodys K, Catalano D, Kurt-Jones E, Mandrekar P, Szabo G (2011) Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 53(2):649–660. https://doi.org/10.1002/hep.24059
Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G (2012) IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 122(10):3476–3489. https://doi.org/10.1172/JCI60777
Petrasek J, Iracheta-Vellve A, Csak T, Satishchandran A, Kodys K, Kurt-Jones EA, Fitzgerald KA, Szabo G (2013) STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc Natl Acad Sci U S A 110(41):16544–16549. https://doi.org/10.1073/pnas.1308331110
Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A, Messer K, Feldstein AE (2014) Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 9(12):e113651. https://doi.org/10.1371/journal.pone.0113651
Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Edward Medof M, Nagy LE (2007) Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132(3):1117–1126. https://doi.org/10.1053/j.gastro.2007.01.053
Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, Hartland SN, Snowdon VK, Cappon A, Gordon-Walker TT, Williams MJ, Dunbar DR, Manning JR, van Rooijen N, Fallowfield JA, Forbes SJ, Iredale JP (2012) Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A 109(46):E3186–E3195. https://doi.org/10.1073/pnas.1119964109
Ricklin D, Reis ES, Lambris JD (2016) Complement in disease: a defence system turning offensive. Nat Rev Nephrol 12(7):383–401. https://doi.org/10.1038/nrneph.2016.70
Roh YS, Seki E (2013) Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 28(Suppl 1):38–42. https://doi.org/10.1111/jgh.12019
Roh YS, Zhang B, Loomba R, Seki E (2015) TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Am J Physiol Gastrointest Liver Physiol 309(1):G30–G41. https://doi.org/10.1152/ajpgi.00031.2015
Saikia P, Bellos D, McMullen MR, Pollard KA, de la Motte C, Nagy LE (2017) MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol. Hepatology 66(2):602–615. https://doi.org/10.1002/hep.29144
Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23(9):1018–1027. https://doi.org/10.1038/nm.4397
Sharland A, Gorrell MD (2009) Cooperation of innate and adaptive immunity in the pathogenesis of biliary atresia: there’s a killer on the run. Hepatology 50(6):2037–2040. https://doi.org/10.1002/hep.23399
Shen H, French BA, Liu H, Tillman BC, French SW (2014) Increased activity of the complement system in the liver of patients with alcoholic hepatitis. Exp Mol Pathol 97(3):338–344. https://doi.org/10.1016/j.yexmp.2014.09.004
Singal AK, Anand BS (2013) Recent trends in the epidemiology of alcoholic liver disease. Clin Liver Dis 2(2):53–56. https://doi.org/10.1002/cld.168
Singal AK, Kodali S, Vucovich LA, Darley-Usmar V, Schiano TD (2016) Diagnosis and treatment of alcoholic hepatitis: a systematic review. Alcohol Clin Exp Res 40(7):1390–1402. https://doi.org/10.1111/acer.13108
Song K, Coleman RA, Zhu X, Alber C, Ballas ZK, Waldschmidt TJ, Cook RT (2002) Chronic ethanol consumption by mice results in activated splenic T cells. J Leukoc Biol 72(6):1109–1116
Stavitsky AB (2007) The innate immune response to infection, toxins and trauma evolved into networks of interactive, defensive, reparative, regulatory, injurious and pathogenic pathways. Mol Immunol 44(11):2787–2799. https://doi.org/10.1016/j.molimm.2007.01.011
Sutti S, Rigamonti C, Vidali M, Albano E (2014) CYP2E1 autoantibodies in liver diseases. Redox Biol 3:72–78. https://doi.org/10.1016/j.redox.2014.11.004
Syn WK, Agboola KM, Swiderska M, Michelotti GA, Liaskou E, Pang H, Xie G, Philips G, Chan IS, Karaca GF, Pereira Tde A, Chen Y, Mi Z, Kuo PC, Choi SS, Guy CD, Abdelmalek MF, Diehl AM (2012) NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease. Gut 61(9):1323–1329. https://doi.org/10.1136/gutjnl-2011-301857
Szabo G, Wands JR, Eken A, Osna NA, Weinman SA, Machida K, Joe Wang H (2010) Alcohol and hepatitis C virus – interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res 34(10):1675–1686. https://doi.org/10.1111/j.1530-0277.2010.01255.x
Tonnesen H, Andersen JR, Pedersen AE, Kaiser AH (1990) Lymphopenia in heavy drinkers – reversibility and relation to the duration of drinking episodes. Ann Med 22(4):229–231
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179–189. https://doi.org/10.1016/j.immuni.2006.01.001
Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS, Gores GJ, Shah VH (2016) Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol 64(3):651–660. https://doi.org/10.1016/j.jhep.2015.11.020
Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, Pecker F, Tran A, Gual P, Mallat A, Lotersztajn S, Pavoine C (2014) M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59(1):130–142. https://doi.org/10.1002/hep.26607
Wang HJ, Gao B, Zakhari S, Nagy LE (2012) Inflammation in alcoholic liver disease. Annu Rev Nutr 32:343–368. https://doi.org/10.1146/annurev-nutr-072610-145138
Wang M, You Q, Lor K, Chen F, Gao B, Ju C (2014) Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol 96(4):657–665. https://doi.org/10.1189/jlb.6A0114-004RR
Wetsman N (2017) Inflammatory illness: why the next wave of antidepressants may target the immune system. Nat Med 23(9):1009–1011. https://doi.org/10.1038/nm0917-1009
Wheeler MD, Kono H, Yin M, Nakagami M, Uesugi T, Arteel GE, Gabele E, Rusyn I, Yamashina S, Froh M, Adachi Y, Iimuro Y, Bradford BU, Smutney OM, Connor HD, Mason RP, Goyert SM, Peters JM, Gonzalez FJ, Samulski RJ, Thurman RG (2001) The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 31(12):1544–1549
Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK, Bowman EP, de Waal Malefyt R (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8(9):950–957. https://doi.org/10.1038/ni1497
Xu MJ, Zhou Z, Parker R, Gao B (2017) Targeting inflammation for the treatment of alcoholic liver disease. Pharmacol Ther. https://doi.org/10.1016/j.pharmthera.2017.06.007
Yeluru A, Cuthbert JA, Casey L, Mitchell MC (2016) Alcoholic hepatitis: risk factors, pathogenesis, and approach to treatment. Alcohol Clin Exp Res 40(2):246–255. https://doi.org/10.1111/acer.12956
Yi HS, Lee YS, Byun JS, Seo W, Jeong JM, Park O, Duester G, Haseba T, Kim SC, Park KG, Gao B, Jeong WI (2014) Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice. Hepatology 60(3):1044–1053. https://doi.org/10.1002/hep.27137
Zhang H, Meadows GG (2005) Chronic alcohol consumption in mice increases the proportion of peripheral memory T cells by homeostatic proliferation. J Leukoc Biol 78(5):1070–1080. https://doi.org/10.1189/jlb.0605317
Zhang H, Zhang F, Zhu Z, Luong D, Meadows GG (2015) Chronic alcohol consumption enhances iNKT cell maturation and activation. Toxicol Appl Pharmacol 282(2):139–150. https://doi.org/10.1016/j.taap.2014.11.013
Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7(12):243. https://doi.org/10.1186/gb-2006-7-12-243
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Kim, A. et al. (2018). Hepatic Immune System: Adaptations to Alcohol. In: Grant, K., Lovinger, D. (eds) The Neuropharmacology of Alcohol . Handbook of Experimental Pharmacology, vol 248. Springer, Cham. https://doi.org/10.1007/164_2017_88
Download citation
DOI: https://doi.org/10.1007/164_2017_88
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-96522-2
Online ISBN: 978-3-319-96523-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)